Annual Cash & Cash Equivalents
$144.30 M
-$11.80 M-7.56%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual cash & cash equivalents is currently $144.30 million, with the most recent change of -$11.80 million (-7.56%) on 31 December 2023. During the last 3 years, it has risen by +$51.65 million (+55.76%). AMPH annual cash & cash equivalents is now -7.56% below its all-time high of $156.10 million, reached on 31 December 2022.AMPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$192.12 M
+$2.50 M+1.32%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly cash and cash equivalents is currently $192.12 million, with the most recent change of +$2.50 million (+1.32%) on 30 September 2024. Over the past year, it has dropped by -$74.66 million (-27.99%). AMPH quarterly cash and cash equivalents is now -27.99% below its all-time high of $266.78 million, reached on 30 September 2023.AMPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.6% | -28.0% |
| 3 y3 years | +55.8% | +80.2% |
| 5 y5 years | +67.1% | +124.4% |
AMPH Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.6% | +55.8% | -28.0% | +80.2% |
| 5 y | 5 years | -7.6% | +95.8% | -28.0% | +250.3% |
| alltime | all time | -7.6% | +187.4% | -28.0% | +299.7% |
Amphastar Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $192.12 M(+1.3%) |
| June 2024 | - | $189.62 M(-5.7%) |
| Mar 2024 | - | $201.15 M(+39.4%) |
| Dec 2023 | $144.30 M(-7.6%) | $144.30 M(-45.9%) |
| Sept 2023 | - | $266.78 M(+79.5%) |
| June 2023 | - | $148.59 M(-15.9%) |
| Mar 2023 | - | $176.62 M(+13.1%) |
| Dec 2022 | $156.10 M(+23.5%) | $156.10 M(-0.7%) |
| Sept 2022 | - | $157.24 M(-5.4%) |
| June 2022 | - | $166.16 M(-3.7%) |
| Mar 2022 | - | $172.63 M(+36.6%) |
| Dec 2021 | $126.35 M(+36.4%) | $126.35 M(+18.5%) |
| Sept 2021 | - | $106.61 M(+1.1%) |
| June 2021 | - | $105.43 M(+3.8%) |
| Mar 2021 | - | $101.60 M(+9.7%) |
| Dec 2020 | $92.64 M(+25.7%) | $92.64 M(+5.4%) |
| Sept 2020 | - | $87.91 M(+0.6%) |
| June 2020 | - | $87.39 M(+59.3%) |
| Mar 2020 | - | $54.84 M(-25.6%) |
| Dec 2019 | $73.69 M | $73.69 M(-13.9%) |
| Sept 2019 | - | $85.61 M(-28.9%) |
| June 2019 | - | $120.37 M(+52.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $79.10 M(-8.4%) |
| Dec 2018 | $86.34 M(+31.6%) | $86.34 M(+25.6%) |
| Sept 2018 | - | $68.73 M(+43.0%) |
| June 2018 | - | $48.07 M(-11.9%) |
| Mar 2018 | - | $54.55 M(-16.8%) |
| Dec 2017 | $65.59 M(-9.3%) | $65.59 M(-2.0%) |
| Sept 2017 | - | $66.92 M(-18.9%) |
| June 2017 | - | $82.54 M(+7.5%) |
| Mar 2017 | - | $76.77 M(+6.1%) |
| Dec 2016 | $72.35 M(+9.5%) | $72.35 M(+8.6%) |
| Sept 2016 | - | $66.60 M(-0.1%) |
| June 2016 | - | $66.66 M(+5.3%) |
| Mar 2016 | - | $63.33 M(-4.1%) |
| Dec 2015 | $66.07 M(-2.6%) | $66.07 M(-6.5%) |
| Sept 2015 | - | $70.68 M(-5.1%) |
| June 2015 | - | $74.46 M(+8.6%) |
| Mar 2015 | - | $68.59 M(+1.1%) |
| Dec 2014 | $67.83 M(+26.6%) | $67.83 M(-6.9%) |
| Sept 2014 | - | $72.88 M(+13.7%) |
| June 2014 | - | $64.08 M(+22.9%) |
| Mar 2014 | - | $52.13 M(-2.7%) |
| Dec 2013 | $53.59 M(+6.7%) | $53.59 M |
| Dec 2012 | $50.21 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Amphastar Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Amphastar Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of AMPH is $144.30 M
What is the all time high annual cash & cash equivalents for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual cash & cash equivalents is $156.10 M
What is Amphastar Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, AMPH annual cash & cash equivalents has changed by -$11.80 M (-7.56%)
What is Amphastar Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AMPH is $192.12 M
What is the all time high quarterly cash and cash equivalents for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly cash and cash equivalents is $266.78 M
What is Amphastar Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, AMPH quarterly cash and cash equivalents has changed by -$74.66 M (-27.99%)